UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000047591
Receipt number R000054272
Scientific Title Efficacy and safety of acupuncture on anorexia and dietary intake loss in patients with chronic respiratory disease (randomized controlled trial)
Date of disclosure of the study information 2022/04/26
Last modified on 2022/04/26 00:27:04

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of Acupuncture Therapy on Anorexia in Chronic Pulmonary diseases

Acronym

EAT-ACUP trial

Scientific Title

Efficacy and safety of acupuncture on anorexia and dietary intake loss in patients with chronic respiratory disease (randomized controlled trial)

Scientific Title:Acronym

Effects of acupuncture on anorexia in Chronic respiratory disease (RCT)

Region

Japan


Condition

Condition

Chronic respiratory disease

Classification by specialty

Pneumology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To estimate the efficacy and safety of acupuncture to improve anorexia and dietary intake loss, and to maintain body weight among patients with chronic respiratory diseases

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

VAS score for appetite

Key secondary outcomes

1) Food intake
2) Body Mass Index
3) nutrition status (Alb, Pre-Alb, retinol-binding protein)
4) 24-hour heart rate variability


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Acupuncture group (group that adds acupuncture to standard treatment)
Twice a week for 5 weeks

Interventions/Control_2

Control group (normal treatment group)
5 weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >

Gender

Male and Female

Key inclusion criteria

1) Patients with chronic respiratory disease who have very low food intake due to loss of appetite
2) Patients with weight loss (5% or more / 6 months) or low BMI (<20 kg / m2)
3) Patients who consented in writing
4) Patients who the doctor has determined to be stable.

Key exclusion criteria

1) Patients with malignant tumors
2) Patients with serious heart disease
3) Patients with severe liver dysfunction
4) Patients with severe renal dysfunction
5) Patients with severe asthma factors
6) Patients with collagen disease (RA, PM / DM, etc.)
7) Patients who have undergone drug changes during clinical trials
8) Patients who have already received acupuncture
9) Patient judged as inappropriate by the researchers

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Hiroshi
Middle name
Last name Kida

Organization

National Hospital Organization Osaka Toneyama Medical Center

Division name

Department of Respiratory Medicine

Zip code

560-8552

Address

5-1-1 Toneyama, Toyonaka, Osaka

TEL

+81668532001

Email

kida.hiroshi.sv@mail.hosp.go.jp


Public contact

Name of contact person

1st name Tomonori
Middle name
Last name Maekura

Organization

National Hospital Organization Osaka Toneyama Medical Center

Division name

Respiratory Science Laboratory

Zip code

560-8552

Address

5-1-1 Toneyama, Toyonaka, Osaka 560-8552, Japan

TEL

+81668532001

Homepage URL


Email

maekura.acupuncture@gmail.com


Sponsor or person

Institute

National Hospital Organization Osaka Toneyama Medical Center

Institute

Department

Personal name



Funding Source

Organization

Grant-in-Aid for Clinical Research from National Hospital Organization in Japan

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Hospital Organization Osaka Toneyama Medical Center

Address

5-1-1 Toneyama, Toyonaka, Osaka 560-8552, Japan

Tel

+81668532001

Email

410-chiken@mail.hosp.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 04 Month 26 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2022 Year 04 Month 15 Day

Date of IRB

2022 Year 04 Month 18 Day

Anticipated trial start date

2022 Year 04 Month 26 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 04 Month 26 Day

Last modified on

2022 Year 04 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054272